Bertin Bioreagent

anti-RXRα (Retinoid X receptor α), mAb (3A2)

As low as CHF 777.00
In stock
Only %1 left
BRT-G01034-R100100 µlCHF 777.00
NEW
 
More Information
Product Details
Synonyms Retinoid X Receptor alpha; Nuclear Receptor Subfamily 2 Group B Member 1; RXRA; NR2B1
Product Type Monoclonal Antibody
Properties
Clone 3A2
Isotype Mouse IgG1κ
Source/Host Mouse
Immunogen/Antigen Recombinant protein, epitope corresponding to DE-region of mouse RXRalpha.
Application ELISA, Western Blot, Immunocytochemistry, Immunohistochemistry, Immunoprecipitation, Gel shift. Recommended dilutions: 1/500-1/5000
Specificity Recognizes mouse and human RXR alpha. No cross-reactivity on RXR beta and RXR gamma.
Formulation Liquid. Does not contain any preservative.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Bertin Bioreagent
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 3 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF
Description
Retinoid X Receptor Alpha (RXRα) is a type of nuclear receptor that functions as a transcription factor. It plays a crucial role in regulating gene expression in response to ligands such as retinoids (derivatives of vitamin A) and other signaling molecules. Retinoid X receptors (RXRs) and retinoic acid receptors (RARs), are nuclear receptors that mediate the biological effects of retinoids by their involvement in retinoic acid-mediated gene activation. RXRα forms homodimers (RXR-RXR) or heterodimers with other nuclear receptors like retinoic acid receptor (RAR), peroxisome proliferator-activated receptors (PPARs), liver X receptor (LXR) or vitamin D receptor (VDR). These dimeric complexes regulate genes involved in cell growth, differentiation, metabolism, and apoptosis. RXRα dysregulation has been linked to various diseases, including cancer, metabolic disorders (e.g., obesity, diabetes), cardiovascular diseases or neurological disorders.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.